This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Top-Performing Leveraged ETFs of This Year So Far
by Sanghamitra Saha
The year 2020 has been marked by the outbreak of the SARS (severe acute respiratory syndrome)-like coronavirus and its resultant impact on global economies and markets.
Top Leveraged/Inverse ETFs of Last Week
by Sanghamitra Saha
Wall Street witnessed moderate movement last week with the S&P 500 and the Nasdaq gaining about 0.7% and 2.7%, respectively, and the Dow Jones showing no movement.
ETFs Riding the Hot Remote Working Trend
by Neena Mishra
We discuss the top-performing leveraged ETFs and the new WFH ETF.
Top Leveraged ETFs of Last Week
by Sanghamitra Saha
The last week was moderate for Wall Street with the S&P 500 gaining about 0.2%, the Dow Jones retreating about 0.8% but the Nasdaq adding about 1.7%
Top 6 Leveraged ETF Areas of First-Half 2020
by Sanghamitra Saha
The first-half of 2020 was marked with the outbreak of SARS (severe acute respiratory syndrome)-like coronavirus.
4 Best-Performing Leveraged ETF Areas of Last Week
by Sanghamitra Saha
Last week witnessed a tug-of-war between bulls and bears.
Best & Worst Leveraged ETFs of Last Week
by Sanghamitra Saha
Inside the top-and-worst-performing leveraged ETFs of last week.
8 Leveraged ETFs That Are Up in Double Digits to Start 2020
by Sweta Killa
U.S. stocks continued their spectacular run to start the New Year. We highlighted eight leveraged equity ETFs that piled up double-digits gain to start 2020.
Bet on Surging China Stocks With These Leveraged ETFs
by Sweta Killa
Amid bullishness, many investors have turned confident on China stocks and are seeking to tap this opportunity with a leveraged play.
Leveraged ETFs That Soared More Than 50% in February
by Sweta Killa
We have highlighted some leveraged equity ETFs that have piled up more than 50% returns in February.
The Zacks Analyst Blog Highlights: NAIL, CWEB, LABU, SOXL and EDC
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NAIL, CWEB, LABU, SOXL and EDC
The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bull 3X ETF, Direxion Daily South Korea Bull 3X ETF, Direxion Daily CSI China Internet Bull 2X Shares, Direxion Daily Hmbldrs&Supls Bull 3X ETF and Direxion Daily MSCI India Bull 3
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bull 3X ETF, Direxion Daily South Korea Bull 3X ETF, Direxion Daily CSI China Internet Bull 2X Shares, Direxion Daily Hmbldrs&Supls Bull 3X ETF and Direxion Daily MSCI India Bull 3x ETF
5 Best Performing Leveraged ETFs of May
by Sweta Killa
Though Wall Street triggered the biggest sell-off of the year in mid-May on Trump controversy, it has unable to lower the risk appetite of investors.